2Cartron JP. RH blood group system and molecular basis of Rh-deficiency[J]. Baillieres Best Pract Res Clin Haematol 1999, 12 (4) :655 - 689.
3Beckers EA, Faas BH, Ligthart P,et al. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene[ J]. Transfusion 1997, 37(6) :616 - 623.
4Avent ND. Antenatal genotyping of the blood groups of the fetus [J]. Vox Sang 1998, 74(Suppl 2) :365 -374.
5Aubin .IT, Le Van Kim C, Mouro I, et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification[J]. Br J Haemato 1997,98 (2) :356-364.
6Lan JC, Chen Q, Wu DL, et al. Genetic polymorphism of RhDnegative apsociated haplotypes in the Chinese [ J ]. J Hum Genet 2000,45(4) : 224 - 227.
7Coghlan G, Zelinski T. DNA microsatellite and linkage analysis supports the inclusion of LOCR in the Rh blood group system [J ]. Transfusion 2003, 43 (4) : 440 - 444.
8Avent ND. The rhesus blood group system: insights from recent advances in molecularbiology [ J]. Transfus Med Rev 1999, 13 (4) :245 - 266.
9Legler TJ, Maas JH, Kohler M, et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis [J]. Transfus Med 2001, 11 (5) :383 - 388.
10Urbaniak SJ. The scientific basis of antenatal prophylaxis [J]. Br J Obstet Gynaecol 1998, 105(Suppl 18) :11 - 18.
